Search results for "COVID-19"
Register now for ACP and Annals of Internal Medicine's COVID-19 Forum X: Current Clinical Challenges in COVID-19 Prevention and Management
During the Sept. 7 virtual live event, a panel of experts will discuss current methods for preventing and managing SARS-CoV-2 infection.
https://immattersacp.org/weekly/archives/2022/08/30/4.htm
30 Aug 2022
Dapagliflozin associated with improved outcomes for HF with mildly reduced or preserved ejection fraction
An industry-funded study found patients with heart failure (HF) and an ejection fraction above 40% had a lower combined risk for worsening HF or cardiovascular death if they were randomly assigned to receive dapagliflozin versus placebo.
https://immattersacp.org/weekly/archives/2022/08/30/5.htm
30 Aug 2022
Latest COVID-19 research on VTE risk, treatment with metformin, ivermectin, fluvoxamine
Unvaccinated patients may have higher risk of venous thromboembolism (VTE) when mildly ill, one study found, while another showed no effect from metformin, ivermectin, or fluvoxamine. Research supported the safety of the mRNA vaccines, and the NIH updated its treatment guidelines.
https://immattersacp.org/weekly/archives/2022/08/23/4.htm
23 Aug 2022
Physician training increased shared decision making at subsequent visits in elderly patients
A U.S. trial found that elderly patients whose physicians had taken a two-hour online course in communication skills were more likely to have had screening discussions focused on shared decision making during a primary care visit.
https://immattersacp.org/weekly/archives/2022/08/16/5.htm
16 Aug 2022
NJ licensure during COVID-19 offers example of how to meet workforce demand
Temporary licensure of out-of-state practitioners, along with telehealth waivers, may be a valuable, short-term solution to mitigating health care workforce shortages during public health emergencies, researchers said.
https://immattersacp.org/weekly/archives/2022/08/09/4.htm
9 Aug 2022
Racial disparities seen in U.S. drug overdose deaths in first year of pandemic
An analysis of CDC data found that while overall U.S. drug overdose deaths increased by 30% from 2019 to 2020, rates increased 44% among non-Hispanic Black and 39% among non-Hispanic American Indian or Alaska Native persons versus 22% in White persons.
https://immattersacp.org/weekly/archives/2022/07/26/2.htm
26 Jul 2022
New COVID-19 vaccine authorized; reviews analyze myocarditis, drug treatments
The FDA gave the Novavax COVID-19 vaccine emergency use authorization for adults. One recent review found lower myocarditis risk with the Pfizer-BioNTech vaccine than the Moderna vaccine, and another looked at the strength of evidence supporting COVID-19 drug treatments.
https://immattersacp.org/weekly/archives/2022/07/19/4.htm
19 Jul 2022
Targeting social needs may help improve type 2 diabetes outcomes, review finds
A systematic review found that HbA1c levels were improved significantly by food supplementation with referral and diabetes support, financial incentives with education and skills training, housing relocation with counseling support, and the integration of nonmedical interventions into medical care.
https://immattersacp.org/weekly/archives/2022/07/05/3.htm
5 Jul 2022
Experts discuss the data on post-COVID-19 symptoms
ACP and Annals of Internal Medicine's ninth COVID-19 forum addressing postacute sequelae of COVID-19 (PASC) offered a better understanding of persistent symptoms after SARS-CoV-2 infection.
https://immattersacp.org/archives/2022/07/experts-discuss-the-data-on-post-covid-19-symptoms.htm
1 Jul 2022
New diabetes drug, new indication for eosinophilic esophagitis
This column reviews details on recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2022/07/new-diabetes-drug-new-indication-for-eosinophilic-esophagitis.htm
1 Jul 2022